- Home
- RFIL vs INGN Comparison
RFIL vs INGN Comparison
Compare RFIL & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RFIL | INGN |
|---|---|---|
| Founded | 1979 | 2001 |
| Country | United States | United States |
| Employees | 289 | N/A |
| Industry | Electrical Products | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 183.3M | 172.4M |
| IPO Year | 1996 | 2013 |
Fundamental Metrics
Financial Performance| Metric | RFIL | INGN |
|---|---|---|
| Price | $17.54 | $6.39 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $11.25 | $11.25 |
| AVG Volume (30 Days) | 209.5K | ★ 335.5K |
| Earning Date | 06-15-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 101.59 | 43.42 |
| EPS | ★ N/A | N/A |
| Revenue | $55,325,000.00 | ★ $348,668,000.00 |
| Revenue This Year | $9.65 | $8.03 |
| Revenue Next Year | $6.40 | $7.76 |
| P/E Ratio | $1,203.00 | ★ N/A |
| Revenue Growth | ★ 10.22 | 3.86 |
| 52 Week Low | $3.98 | $5.34 |
| 52 Week High | $19.00 | $9.13 |
Technical Indicators
Market Signals| Indicator | RFIL | INGN |
|---|---|---|
| Relative Strength Index (RSI) | 64.53 | 42.70 |
| Support Level | $6.28 | $5.97 |
| Resistance Level | $19.00 | $6.93 |
| Average True Range (ATR) | 1.35 | 0.36 |
| MACD | 0.06 | -0.09 |
| Stochastic Oscillator | 75.76 | 19.05 |
Price Performance
Historical ComparisonAbout RFIL RF Industries Ltd.
RF Industries Ltd is engaged in the design, manufacture, and marketing of interconnect products and systems, including coaxial and specialty cables, fiber optic cables and connectors, and electrical and electronic specialty cables. The company has one operating segment. The company operates in Canada, Germany, China, the USA, and the United Kingdom, and Others.
About INGN Inogen Inc
Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.